Literature DB >> 1468153

High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease.

T Jimi1, Y Wakayama, S Shibuya, H Nakata, T Tomaru, Y Takahashi, K Kosaka, T Asano, K Kato.   

Abstract

Concentrations of several proteins that are characteristic of the nervous system were time-sequentially analyzed by radio- and enzyme-immunoassay in the cerebrospinal fluid (CSF) of patients with Creutzfeldt-Jakob disease (CJD). We found abnormally high levels of several proteins, such as neuron-specific enolase (NSE), S-100b protein, brain-type isozyme of creatine kinase (CK-BB) and alpha subunit of GTP binding protein G0 (G0 alpha) in the early stage of the disease. Generally, these protein levels were far higher in CJD patients than in normal controls and other neurological patients in the early stage before the typical clinical manifestations were evident. These levels increased to maxima when the disease activity was most prominent and returned to normal or mildly elevated levels in the terminal stage. The results imply that these protein levels can serve as biochemical markers for the presence of an active destructive process in CJD brain and provide us with a useful indicator for early diagnosis of CJD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468153     DOI: 10.1016/0009-8981(92)90103-w

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study.

Authors:  M Otto; J Wiltfang; E Schütz; I Zerr; A Otto; A Pfahlberg; O Gefeller; M Uhr; A Giese; T Weber; H A Kretzschmar; S Poser
Journal:  BMJ       Date:  1998-02-21

Review 2.  Cerebrospinal fluid.

Authors:  E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

3.  Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.

Authors:  A J Green; E J Thompson; G E Stewart; M Zeidler; J M McKenzie; M A MacLeod; J W Ironside; R G Will; R S Knight
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

4.  Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.

Authors:  Pascual Sanchez-Juan; Raquel Sánchez-Valle; Alison Green; Anna Ladogana; Natividad Cuadrado-Corrales; Eva Mitrová; Kathrina Stoeck; Theodoros Sklaviadis; Jerzy Kulczycki; Klaus Hess; Anna Krasnianski; Michele Equestre; Danka Slivarichová; Albert Saiz; Miguel Calero; Maurizio Pocchiari; Richard Knight; Cornelia M van Duijn; Inga Zerr
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

5.  Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.

Authors:  Byungki Jang; Eunah Kim; Jin-Kyu Choi; Jae-Kwang Jin; Jae-Il Kim; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

6.  Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.

Authors:  Ilse S Pienaar; Timothy Schallert; Suzél Hattingh; William M U Daniels
Journal:  J Neural Transm (Vienna)       Date:  2009-06-06       Impact factor: 3.575

7.  Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?

Authors:  Constanze Boesenberg-Grosse; Walter J Schulz-Schaeffer; Monika Bodemer; Barbara Ciesielczyk; Bettina Meissner; Anna Krasnianski; Mario Bartl; Uta Heinemann; Daniela Varges; Sabina Eigenbrod; Hans A Kretzschmar; Alison Green; Inga Zerr
Journal:  BMC Neurol       Date:  2006-09-21       Impact factor: 2.474

8.  Urinary alpha1-antichymotrypsin: a biomarker of prion infection.

Authors:  Gino Miele; Harald Seeger; Denis Marino; Ralf Eberhard; Mathias Heikenwalder; Katharina Stoeck; Max Basagni; Richard Knight; Alison Green; Francesca Chianini; Rudolf P Wüthrich; Christoph Hock; Inga Zerr; Adriano Aguzzi
Journal:  PLoS One       Date:  2008-12-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.